EZPW vs. ABT
EZPW (EZCORP, Inc.) and ABT (Abbott Laboratories) are both stocks. EZPW operates in Credit Services (Financial Services), while ABT operates in Medical Devices (Healthcare). Over the past 10 years, EZPW returned 16.75%/yr vs 10.35%/yr for ABT. At a 0.11 correlation, their price movements are largely independent.
Performance
EZPW vs. ABT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, EZPW achieves a 63.95% return, which is significantly higher than ABT's -29.78% return. Over the past 10 years, EZPW has outperformed ABT with an annualized return of 16.75%, while ABT has yielded a comparatively lower 10.35% annualized return.
EZPW
- 1D
- 2.51%
- 1M
- -2.36%
- YTD
- 63.95%
- 6M
- 58.64%
- 1Y
- 139.22%
- 3Y*
- 55.55%
- 5Y*
- 33.75%
- 10Y*
- 16.75%
ABT
- 1D
- 0.02%
- 1M
- -0.63%
- YTD
- -29.78%
- 6M
- -29.78%
- 1Y
- -33.61%
- 3Y*
- -3.93%
- 5Y*
- -2.65%
- 10Y*
- 10.35%
EZPW vs. ABT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
EZPW EZCORP, Inc. | 63.95% | 58.92% | 39.82% | 7.24% | 10.58% | 53.86% | -29.77% | -11.77% | -36.64% | 14.55% |
ABT Abbott Laboratories | -29.78% | 12.87% | 4.81% | 2.26% | -20.68% | 30.53% | 28.04% | 22.08% | 29.06% | 52.03% |
Correlation
The correlation between EZPW and ABT is 0.02, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.02 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.09 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.15 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.14 |
Correlation (All Time) Calculated using the full available price history since Aug 28, 1991 | 0.11 |
The correlation between EZPW and ABT shifts across timeframes, from 0.02 (1 year) to 0.15 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
EZPW:
$2.66B
ABT:
$151.97B
EZPW:
$1.76
ABT:
$3.59
EZPW:
18.07
ABT:
24.24
EZPW:
0.12
ABT:
1.51
EZPW:
1.79
ABT:
3.37
EZPW:
2.37
ABT:
2.30
EZPW:
$1.48B
ABT:
$45.13B
EZPW:
$865.21M
ABT:
$25.45B
EZPW:
$256.16M
ABT:
$10.80B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
EZPW vs. ABT — Risk / Return Rank
EZPW
ABT
EZPW vs. ABT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for EZCORP, Inc. (EZPW) and Abbott Laboratories (ABT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| EZPW | ABT | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 4.21 | -1.41 | +5.62 |
Sortino ratioReturn per unit of downside risk | 4.89 | -1.91 | +6.80 |
Omega ratioGain probability vs. loss probability | 1.62 | 0.74 | +0.88 |
Calmar ratioReturn relative to maximum drawdown | 13.15 | -0.86 | +14.02 |
Martin ratioReturn relative to average drawdown | 35.47 | -2.00 | +37.47 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| EZPW | ABT | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 4.21 | -1.41 | +5.62 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 1.00 | -0.12 | +1.12 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.43 | 0.44 | -0.01 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.11 | 0.49 | -0.38 |
Drawdowns
EZPW vs. ABT - Drawdown Comparison
The maximum EZPW drawdown since its inception was -97.28%, which is greater than ABT's maximum drawdown of -45.66%. Use the drawdown chart below to compare losses from any high point for EZPW and ABT.
Loading charts...
Drawdown Indicators
| EZPW | ABT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.28% | -45.66% | -51.62% |
Max Drawdown (1Y)Largest decline over 1 year | -10.65% | -38.99% | +28.34% |
Max Drawdown (3Y)Largest decline over 3 years | -20.51% | -39.64% | +19.13% |
Max Drawdown (5Y)Largest decline over 5 years | -35.94% | -39.64% | +3.70% |
Max Drawdown (10Y)Largest decline over 10 years | -76.59% | -39.64% | -36.95% |
Current DrawdownCurrent decline from peak | -16.36% | -36.40% | +20.04% |
Average DrawdownAverage peak-to-trough decline | -59.12% | -10.83% | -48.29% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.94% | 16.86% | -12.92% |
Volatility
EZPW vs. ABT - Volatility Comparison
EZCORP, Inc. (EZPW) has a higher volatility of 11.44% compared to Abbott Laboratories (ABT) at 7.34%. This indicates that EZPW's price experiences larger fluctuations and is considered to be riskier than ABT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| EZPW | ABT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.44% | 7.34% | +4.10% |
Volatility (6M)Calculated over the trailing 6-month period | 24.93% | 18.93% | +6.00% |
Volatility (1Y)Calculated over the trailing 1-year period | 33.27% | 23.96% | +9.31% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 33.95% | 21.97% | +11.98% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 39.25% | 23.63% | +15.62% |
Dividends
EZPW vs. ABT - Dividend Comparison
EZPW has not paid dividends to shareholders, while ABT's dividend yield for the trailing twelve months is around 2.80%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABT Abbott Laboratories | 2.80% | 1.88% | 1.95% | 1.85% | 1.71% | 1.28% | 1.32% | 1.47% | 1.55% | 1.86% | 2.71% | 2.14% |
EZPW EZCORP, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
EZPW vs. ABT - Financials Comparison
This section allows you to compare key financial metrics between EZCORP, Inc. and Abbott Laboratories. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
EZPW vs. ABT - Profitability Comparison
EZPW - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, EZCORP, Inc. reported a gross profit of 260.04M and revenue of 446.88M. Therefore, the gross margin over that period was 58.2%.
ABT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Abbott Laboratories reported a gross profit of 6.28B and revenue of 11.16B. Therefore, the gross margin over that period was 56.3%.
EZPW - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, EZCORP, Inc. reported an operating income of 67.84M and revenue of 446.88M, resulting in an operating margin of 15.2%.
ABT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Abbott Laboratories reported an operating income of 1.84B and revenue of 11.16B, resulting in an operating margin of 16.5%.
EZPW - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, EZCORP, Inc. reported a net income of 49.10M and revenue of 446.88M, resulting in a net margin of 11.0%.
ABT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Abbott Laboratories reported a net income of 1.08B and revenue of 11.16B, resulting in a net margin of 9.7%.
Frequently Asked Questions
EZPW and ABT have a correlation of 0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
EZPW has higher volatility (11.44%) compared to ABT (7.34%). In terms of maximum drawdown, EZPW dropped -97.28% vs ABT's -45.66%.
EZPW currently has the higher Sharpe Ratio (4.21 vs -1.41), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for EZPW and ABT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer